SCHEMBL2596732

SCHEMBL2596732

CCOP(C)(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.74
CA2 P00918 2/20 0.74
BCHE P06276 1/20 0.74
ACHE P22303 1/20 0.74
MAPK1 P28482 3/20 0.68
ALDH1A1 P00352 3/20 0.68
CYP3A4 P08684 2/20 0.68
HSD17B10 Q99714 2/20 0.68
TSHR P16473 1/20 0.68
CES2 O00748 1/20 0.56
CES1 P23141 1/20 0.56
LMNA P02545 2/20 0.51
TP53 P04637 1/20 0.51
THRB P10828 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PTGS2 P35354 1/20 0.49
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.46
BCL9 O00512 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15086926 0.88 CA1 (0.61) CA1CA2BCHEACHEMAPK1
SCHEMBL1363813 0.86 CA1 (0.67) CA1CA2BCHEACHEMAPK1
Paraoxon SCHEMBL21114409 0.85 CA1 (1.00) CA1CA2BCHEACHEMAPK1
Paraoxon SCHEMBL26405 0.85 CA1 (1.00) CA1CA2BCHEACHEMAPK1
SCHEMBL6259754 0.85 CA1 (0.94) CA1CA2BCHEACHEMAPK1
SCHEMBL19106914 0.83 CA1 (0.56) CA1CA2BCHEACHEMAPK1
P-Nitrophenyl-O-Ethyl Ethylphosphonate SCHEMBL29350630 0.83 CA1 (0.72) CA1CA2BCHEACHEMAPK1
SCHEMBL2545948 0.83 CES2 (0.73) CA1CA2BCHEACHEMAPK1
SCHEMBL6267678 0.83 CA1 (0.72) CA1CA2BCHEACHEMAPK1
SCHEMBL25931268 0.81 ALDH1A1 (0.65) CA1CA2BCHEACHEMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113686336-B Method for improving underwater navigation precision based on grid topological structure iterative optimal ring domain point 中国空间技术研究院 2024-05-14 CN claimed
US-20130343994-A1 Cholinesterase Inhibitors THE UNIVERSITY OF MONTANA (US) 2013-12-26 US claimed
CN-121742936-A Processor, electronic equipment and calling method of security service 北京奕斯伟计算技术股份有限公司 2026-03-27 CN disclosed
US-20260071323-A1 ATOMIC LAYER DEPOSITION APPARATUS SAMSUNG DISPLAY CO LTD (KR) 2026-03-12 US disclosed
US-20250180497-A1 IMPROVED SURFACE ANALYSIS PROCESS AND DEVICE Photoelectron Intellectual Property Holdings LLC 2025-06-05 US disclosed
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES UNIVERSITY OF WASHINGTON 2025-04-03 US disclosed
EP-3687088-B1 METHOD FOR TRANSMITTING DATA IN OPTICAL NETWORK AND OPTICAL NETWORK DEVICE HUAWEI TECH CO LTD (CN) 2025-03-26 EP disclosed
CN-119155803-A Remote line inspection wireless network and link system 北京凯丰源信息技术股份有限公司 2024-12-17 CN disclosed
EP-4396566-A1 IMPROVED SURFACE ANALYSIS PROCESS AND DEVICE Photoelectron Intellectual Property Holdings LLC (US) 2024-07-10 EP disclosed
CN-113686336-B Method for improving underwater navigation precision based on grid topological structure iterative optimal ring domain point 中国空间技术研究院 2024-05-14 CN disclosed
CN-117940764-A Improved surface analysis method and device 光电子知识产权有限责任公司 2024-04-26 CN disclosed
US-20110071334-A1 FOAMING DECONTAMINATING AQUEOUS SOLUTION COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2011-03-24 US disclosed
US-20110027869-A1 Compositions for Chemical and Biological Defense MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-02-03 US disclosed
EP-0923370-B1 ACETYL CHOLINE ESTERASE INHIBITORS FOR TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING CURAPATH AB (SE) 2005-11-16 EP disclosed
WO-2002072025-A2 IMPROVING POSTSYNAPTIC RESPONSE BY A COMBINATION OF 4-MINOPYRIDINE AND AGONIST THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) 2002-09-19 WO disclosed
CN-1060781-C Phosphonootropic monoester nucleic acids, process for their preparation and their use HOECHST AG (DE) 2001-01-17 CN disclosed
US-6034117-A Methods of treating and diagnosing sleep disordered breathing and means for carrying out the method PHARMAPNEA AB (SE) 2000-03-07 US disclosed
EP-0923370-A2 METHOD OF TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING AND MEANS FOR CARRYING OUT THE METHOD A+ Science Invest AB (SE) 1999-06-23 EP disclosed
WO-1997022339-A1 METHOD OF TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING AND MEANS FOR CARRYING OUT THE METHOD HEDNER JAN (SE) 1997-06-26 WO disclosed
CN-1138588-A Phosphonootropic monoester nucleic acids, process for their preparation and their use HOECHST AG (DE) 1996-12-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES DHFR, CCNH, ODC1 CA1 3714/4885CA2 4658/4885BCHE 212/4885
US-20130343994-A1 Cholinesterase Inhibitors BCHE, ACHE, BACE1 CA1 418/4885CA2 2259/4885BCHE 1/4885
US-20110027869-A1 Compositions for Chemical and Biological Defense LPO, MPO, GPX4 CA1 183/4885CA2 209/4885BCHE 34/4885
US-20260071323-A1 ATOMIC LAYER DEPOSITION APPARATUS VEGFA, NOX4, EXOSC9 CA1 3482/4885CA2 4067/4885BCHE 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.